Fig. 3: Prognostic association of combined bone marrow MRD and imaging response assessment.
From: Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma
Kaplan–Meier curves contrasting participants with no detectable disease on WB-MRI and bone marrow MRD (RAC1 AND MRD neg) at day 100 post-ASCT, those with detectable disease by either imaging or MRD (RAC2 + OR MRD pos) and those with detectable disease by both methods (RAC2 + AND MRD pos). Summary A, Kaplan-Meier curves for PFS B, and Kaplan Meier curves for OS C.
